CLS CELESTICA INC
Printed Circuit Boards · NYSE · SEC CIK 1030894 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY61.6%
TTM net income YoY73.8%
TTM EPS YoY72.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin11.5%
Operating margin8.3%
Net margin6.8%
FCF margin3.0%
EBITDA margin9.3%
Returns
ROE30.2%
ROA11.5%
ROIC (approx.)46.2%
Asset turnover1.68x
Leverage & solvency
Liabilities / assets59.0%
Debt / equity0.13x
Current ratio1.61x
Interest coverage20.36x
Cash quality & payout
Operating cash flow / net income1.13x
Accruals ratio-1.5%
Payout ratio—
Capex / revenue4.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $5.83B | $4.70B | $4.05B | $3.65B | $3.19B | $2.89B | $2.65B | $2.55B |
| Cost of revenue | $5.19B | $4.12B | $3.61B | $3.22B | $2.78B | $2.52B | $2.37B | $2.25B |
| Gross profit | $640.80M | $577.50M | $437.20M | $433.10M | $416.10M | $371.00M | $273.90M | $297.20M |
| R&D expense | $51.20M | $46.30M | $41.20M | $30.20M | $36.40M | $34.00M | $17.60M | $23.40M |
| SG&A expense | $118.20M | $58.10M | $117.40M | $70.10M | $38.40M | $38.90M | $112.50M | $57.60M |
| Operating income | $460.00M | $458.30M | $272.10M | $314.40M | $325.00M | $272.50M | $128.80M | $202.60M |
| Interest expense | $24.10M | $21.20M | $16.00M | $12.60M | $13.80M | $14.40M | $13.70M | $11.90M |
| Pretax income | $455.80M | $441.60M | $256.30M | $301.30M | $310.90M | $257.30M | $113.70M | $189.50M |
| Income tax | $58.60M | $72.80M | $44.00M | $33.80M | $43.10M | $46.30M | $27.50M | $37.80M |
| Net income | $397.20M | $368.80M | $212.30M | $267.50M | $267.80M | $211.00M | $86.20M | $151.70M |
| EBITDA | $508.50M | $502.30M | $311.70M | $367.10M | $365.30M | $317.80M | $166.20M | $242.60M |
| EPS (basic) | 3.30 | 3.21 | 1.85 | — | 2.33 | 1.83 | 0.74 | — |
| EPS (diluted) | 3.26 | 3.17 | 1.83 | — | 2.31 | 1.82 | 0.74 | — |
| Weighted avg. shares (diluted) | 121.80M | 116.20M | 115.70M | — | 115.90M | 115.90M | 116.90M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $3.96B | $535.70M | $378.00M | $595.60M | $305.90M | $313.80M | $303.00M | $423.30M |
| Inventory | $4.51B | $3.40B | $2.67B | $2.19B | $2.05B | $1.92B | $1.79B | $1.76B |
| Current assets | $12.54B | $7.57B | $6.40B | $5.67B | $5.14B | $4.77B | $4.38B | $4.51B |
| PP&E, net | $1.40B | $1.03B | $711.30M | $586.00M | $551.90M | $549.40M | $536.50M | $537.20M |
| Goodwill | $333.30M | $332.90M | $333.00M | $333.10M | $340.70M | $340.80M | $340.50M | $340.50M |
| Intangibles | $234.20M | $244.90M | $255.60M | $266.20M | $275.40M | $286.80M | $297.50M | $308.00M |
| Total assets | $15.14B | $9.79B | $8.26B | $7.21B | $6.61B | $6.24B | $5.83B | $5.99B |
| Current liabilities | $7.77B | $6.18B | $5.08B | $3.94B | $3.50B | $3.32B | $3.05B | $3.02B |
| Short-term debt | $27.30M | $26.40M | $25.90M | $26.00M | $27.40M | $26.60M | $26.70M | $26.50M |
| Long-term debt | $791.50M | $784.00M | $746.50M | $750.50M | $756.70M | $848.60M | $915.00M | $770.20M |
| Total debt | $818.80M | $810.40M | $772.40M | $776.50M | $784.10M | $875.20M | $941.70M | $796.70M |
| Total liabilities | $8.92B | $7.31B | $6.16B | $5.00B | $4.58B | $4.48B | $4.28B | $4.09B |
| Shareholders' equity | $6.21B | $2.48B | $2.10B | $2.22B | $2.03B | $1.76B | $1.56B | $1.90B |
| Net debt | -$3.14B | $274.70M | $394.40M | $180.90M | $478.20M | $561.40M | $638.70M | $373.40M |
| Shares outstanding | — | — | — | 114.91M | — | — | — | 116.07M |
| Cash flow statement | ||||||||
| Operating cash flow | $389.70M | $410.90M | $356.30M | $250.60M | $126.20M | $152.40M | $130.30M | $143.40M |
| Capital expenditure | $274.10M | $263.80M | $229.50M | $94.70M | $37.30M | $32.50M | $36.70M | $47.60M |
| Free cash flow | $115.60M | $147.10M | $126.80M | $155.90M | $88.90M | $119.90M | $93.60M | $95.80M |
| Investing cash flow | -$262.20M | -$266.30M | -$218.40M | -$94.70M | -$37.30M | -$35.00M | -$36.70M | -$51.00M |
| Financing cash flow | $3.30B | $13.10M | -$355.50M | $133.80M | -$96.80M | -$106.60M | -$213.90M | -$67.60M |
| Depreciation & amortization | $48.50M | $44.00M | $39.60M | $52.70M | $40.30M | $45.30M | $37.40M | $40.00M |
| Stock-based compensation | $21.30M | $19.30M | $30.50M | $13.00M | $15.60M | $15.20M | $26.00M | $10.10M |
| Share buybacks | $0 | $0 | $22.60M | $35.70M | $0 | $40.00M | $77.70M | $25.50M |
Free plan shows the latest 8 periods; Pro shows all 11 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.